Equities

Alfresa Holdings Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Alfresa Holdings Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)2,557.50
  • Today's Change20.00 / 0.79%
  • Shares traded677.80k
  • 1 Year change+21.21%
  • Beta0.0376
Data delayed at least 15 minutes, as of Feb 13 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Alfresa Holdings Corporation is a Japan-based holding company primarily engaged in the wholesale of drugs. The Company operates in four business segments. The Pharmaceutical Wholesale segment is engaged in the wholesale of medical products, test reagents, as well as medical equipment and materials. The Self Medication Wholesale segment is engaged in the wholesale of general drugs. The Pharmaceutical Manufacture segment is engaged in the manufacture and sale of pharmaceuticals, test reagents, medical equipment and implements, as well as pharmaceutical powders. The Medical-Related segment is mainly engaged in operation of pharmacies. The others business is engaged in the information system business, the transportation business, the warehousing business, the insurance agency business, the real estate management business, the sale of miscellaneous goods, as well as the manpower dispatching business, among others.

  • Revenue in JPY (TTM)3.06tn
  • Net income in JPY33.64bn
  • Incorporated2003
  • Employees12.45k
  • Location
    Alfresa Holdings Corp23F, Ote Center Bldg., 1-1-3, Ote-machiCHIYODA-KU 100-0004JapanJPN
  • Phone+81 352195100
  • Fax+81 352195103
  • Websitehttps://www.alfresa.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Japan Lifeline Co Ltd58.20bn9.07bn98.75bn1.25k10.711.549.181.70129.28129.28829.90900.800.79181.293.9746,563,200.0012.348.9914.8111.2659.7858.1215.5812.652.09--0.048672.6310.171.8123.983.76-9.0512.82
PHC Holdings Corp363.93bn3.54bn129.26bn9.04k37.190.81014.290.355227.4327.432,861.021,259.090.66233.405.2440,253,730.000.60380.1061.120.161745.2546.910.91170.17380.36061.640.6084916.512.175.81181.3214.73-1.83--
Menicon Co Ltd123.91bn6.85bn139.94bn4.33k20.021.448.361.1391.0791.071,629.401,267.140.61232.528.5528,650,640.003.394.124.195.1453.6753.025.545.611.86--0.442129.354.567.5323.876.7221.9814.87
Hogy Medical Co Ltd37.84bn222.00m150.99bn1.41k648.241.9426.663.9910.3410.341,754.863,454.270.39192.752.8726,856,640.000.22993.510.25233.8632.3037.880.58679.384.1460.780.140454.660.09721.00-45.79-22.76-12.153.92
As One Corp107.58bn8.97bn168.90bn731.0017.912.3415.651.57125.12125.121,500.44959.871.126.053.11147,174,000.009.387.8112.6210.7230.4230.598.348.062.24--0.072751.928.608.079.726.64-16.129.16
Mani Inc30.14bn4.94bn171.42bn4.14k31.942.8923.015.6950.1650.16305.99555.200.51561.6110.587,280,435.008.4510.449.0711.1964.6163.2116.4021.956.27--0.001261.755.1014.54-26.146.8831.5612.13
Nakanishi Inc81.18bn-2.40bn223.08bn2.18k--1.7665.392.75-29.41-29.41969.191,373.650.50981.398.47---1.518.35-1.849.7356.7459.43-2.9516.562.57--0.190138.605.3719.69-127.96--34.8412.47
Ship Healthcare Holdings Inc708.37bn13.99bn258.57bn7.81k18.291.7012.320.365149.82149.827,579.631,609.071.8518.395.1990,758,740.003.573.657.207.009.4110.411.932.251.16--0.15633.317.496.969.715.091.879.11
Nipro Corp652.61bn15.20bn259.93bn39.17k18.590.96913.170.398381.5681.563,649.421,564.270.55641.793.9316,661,790.001.451.112.371.7130.1029.842.612.010.7634.880.675242.899.857.81-53.97--5.7413.12
Nihon Kohden Corp230.96bn12.37bn289.95bn6.11k22.411.6016.251.2675.6975.691,415.011,062.470.93691.813.8837,775,760.005.048.436.5411.0851.8851.545.388.492.31--0.12928.591.554.03-17.207.4319.3912.12
Fukuda Denshi Co Ltd138.47bn17.96bn336.71bn3.47k13.891.3411.452.43642.29642.294,964.156,648.580.6513.954.0939,962,190.008.448.579.8010.6354.0050.2812.9712.343.32--0.009829.45-0.93780.8279-0.470814.13-0.247916.80
Alfresa Holdings Corporation3.06tn33.64bn489.25bn12.45k13.820.93610.030.1598185.04185.0416,819.642,732.391.9014.394.14245,889,200.002.112.056.105.337.077.171.111.021.02--0.056942.103.591.87-7.34-7.42-0.43934.73
ASAHI INTECC CO., LTD.94.59bn9.68bn689.86bn9.47k71.91--41.117.2936.1636.16----------9,985,432.00--8.09--9.5168.8566.0210.2813.78--33.10--35.6011.6016.24-19.436.77-2.4722.43
Data as of Feb 13 2026. Currency figures normalised to Alfresa Holdings Corp's reporting currency: Japanese Yen JPY

Institutional shareholders

30.17%Per cent of shares held by top holders
HolderShares% Held
Silchester International Investors LLPas of 29 Oct 202523.17m12.11%
The Vanguard Group, Inc.as of 07 Jan 20266.69m3.50%
Nomura Asset Management Co., Ltd.as of 08 Jan 20266.22m3.25%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 13 Sep 20245.77m3.02%
Norges Bank Investment Managementas of 30 Jun 20253.18m1.66%
Amova Asset Management Co., Ltd.as of 13 Sep 20243.13m1.64%
Daiwa Asset Management Co. Ltd.as of 30 Dec 20252.79m1.46%
Dimensional Fund Advisors LPas of 08 Jan 20262.54m1.33%
BlackRock Fund Advisorsas of 09 Jan 20262.29m1.20%
Wellington Management Co. LLPas of 31 Dec 20251.94m1.02%
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.